Side-Effects of Januvia® and Janumet® currently being investigated by The Mulligan Law Firm:

Severe and even fatal responses to Januvia® and Janumet® have been reported, such as:

•Death, Acute Pancreatitis, Necrotizing Pancreatitis, Hemorrhagic Pancreatitis

and

•Cutaneous Vasculitis

If you or a loved one have been prescribed Januvia or Janumet and have experienced any of these side-effects, please contact us immediately for a free consultation.

Always see your physician before you stop taking any medications, including Januvia® or Janumet®. 

If you have taken Januvia and have questions, please do not hesitate to contact us immediately.

The DePuy Articular Surface Replacement Hip Implant is a hip replacement cup manufactured by DePuy, a division of Johnson & Johnson.  DePuy Orthopaedics withdrew the hip device after more than two years of reports that the hip implant, called an ASR, failed in patients only a few years after implant.  This failure required costly and painful replacement operations. 

The device was first used in the United States in 2005.

Withdrawn from the Australian Market in December 2009, it is under scrutiny in the U.S. and has been withdrawn from the domestic market.

The FDA has received, beginning in 2008, about 300 complaints about the early failure of the implanted device.

On March 9, 2010, DePuy announced that the DePuy ASR Hip Replacement would be discontinued in the U.S. market because it was failing and requiring remedial surgeries.

The same release mentions a higher failure rate in smaller-boned patients and those with certain bone weaknesses.

There is no FDA recall at this time.  Please check back at this website for updates from time to time.

The ASR hip cup is a metal-on-metal ball and socket, large diameter hip resurfacing device.

The cause of the DePuy ASR Cup hip implant failures is still not known. 
 
Metal debris early in the life of this implant can cause inflammation, leading to damaged muscles and soft tissue.

Among the primary and most serious side-effects mentioned in the ASR hip cup revision reports:

>Implanted cup loosening or failing to bond
>Pseudotumour: a soft tissue mass that may be the result of a toxic reaction to an excess of particulate metal wear debris.
>ALVAL (Aseptic Lymphocyte Dominated Vasculitis Associated Lesion): an adverse tissue reaction to metal particles and ions.
>Metallosis: condition of excessive metal debris.

If you or a loved one has been seriously injured after surgical implantation of a DePuy Acetabular Cup, please contact us immediately for a free consultation as soon as possible.

We would like to speak with you immediately if you have any of the following diagnoses from denture cream use:

•  Neuropathy
•  Zinc Poisoning
•  Hypocupremia and/or 
•  Hyperzincemia

Various brands of denture creams help to adhere dentures to an individual’s gums and help stop pain and discomfort while wearing dentures. Zinc is found in some denture creams and can be harmful when individuals are exposed to toxic levels.

Fixodent® and Super Poligrip® are two denture creams that contain zinc.

Excessive zinc exposire can lead to several significant health problems.

Research has found that users of denture creams such as Fixodent® and Super Poligrip® are at risk for zinc poisoning.

Zinc Poisoning symptoms include:

- paralysis
- weakness in the extremities
- lack of coordination and/or poor balance
- pain in the extremities
- tingling or numbness
- difficulty urinating
- loss of sensation

Excess levels of Zinc in the blood can also result in the following diagnoses:

- ZINC POISONING
- MYELOPATHY (SPINAL CORD DAMAGE)
- COPPER DEFICIENCY – HYPOCUPREMIA
- NEUROPATHY
- ANEMIA
AND/OR
- BONE MARROW FAILURE

If you or a loved one have used denture creams of any kind and suffer from these or other significant symptoms / injuries, you may be entitled to compensation. Contact The Mulligan Law Firm immediately via this website or 1-866-529-0001, Ext. 245.  Se Habla Espanol

Timeline

August 2008: the FDA issues a MedWatch alert about six new cases of hemorrhagic and necrotizing pancreatitis that had been reported to FDA.

March 2009: drug regulators in the UK published an article discussing two serious side effects potentially associated with Byetta®, pancreatitis and renal (kidney) impairment.

November 2009: more news from the FDA: in a limited study from April 2005 through October 2008, the FDA received reports of 78 cases of altered kidney function (62 cases of acute renal failure and 16 cases of renal insufficiency) in patients using Byetta®.

The side-effects detailed in the study ranged from the mild, to death (4 cases).

The FDA carefully recognized that some of the cases concerned patients who already had kidney disease or had one or more risk factors for developing kidney problems already.

During the time period of the case study, Byetta® had been prescribed nearly 7 million times. (FDA)

What are the Side-Effects?

Milder side-effects include nausea, vomiting,  and diarrhea.

These were the most common side effects linked to with Byetta®; it is a possibility that these side effects contributed to the development of altered kidney function in the reported cases.

Side-effects that are more severe include kidney dysfunction, renal failure, pancreatitis, and even death.

If you or a loved one have been prescribed Byetta® and now have been diagnosed with renal failure, altered kidney function, or pancreatitis, please contact us immediately for a free consultation. You could be entitled to compensation.

Contact Eric W. Gruenwald, Lawyer, for more information at 866-529-0001 Extension 245.

Always consult with your physician before you stop taking any medications, including Byetta®.

Insulin glargine is biosynthetic insulin that imitates NPH human insulin and is prescribed in the treatment of diabetes. This is marketed under the brand name Lantus® by Sanofi-Aventis. Administered through injection, Lantus provides a regulated release which translates into a glucose-lowering effect spread over 24-hours.

Side Effects of Lantus®

The usage of Lantus® has been associated with a greater risk of developing cancer and this has been substantiated through studies. On June 26,2009, Diabetologia, an online journal on diabetes published some new research based on studies conducted on patients drawn from Scotland, Sweden, UK and Germany. A look at the German study revealed that the research on approximately 127,000 patients who used Lantus® showed a link between its usage and a greater risk of developing cancer.

The Diabetologia press release stated that, “Compared with people using similar doses of human insulin, out of every 100 people who used Lantus® insulin over an average of about one-and-a-half years, one additional person was diagnosed with cancer.”

Lantus® & FDA

Lantus® was the first FDA approved long-acting (basal) recombinant human insulin analog.   Based on recent studies, the FDA MedWatch Safety Alert acknowledges that those on Lantus® could be facing an increased risk of developing cancer.

The Law & Lantus®

If you or your loved one has been using Lantus® and developed cancer, you could be potentially entitled to compensation. Contact Eric W. Gruenwald, Attorney / Lawyer for more information at 866-529-0001 Extension 245. Never discontinue any medication without the consent of your physician.

Along with other side-effects, Accutane® is suspected as a possible cause of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. Even after treatment with Accutane has been discontinued, these serious digestive disorders can persist.

If someone has taken the acne medication Accutane and is now diagnosed with Crohn’s disease or Ulcerative colitis, they may be entitled to compensation. Contact the Mulligan Law Firm at www.mulliganlaw.com

Dallas, TX September 30, 2009 — Accutane (also known as Isotretinoin) has been used by about 13 million people since it first became available in 1982. Its primary use is for the treatment of severe nodular acne, in patients who fail to respond to other acne treatments such as antibiotics.

Accutane works by reducing the amount of oil released by oil-glands in the skin, and helps the skin to renew itself. It was Roche’s second-biggest selling drug until the patent expired in 2003, at which time generic versions could be sold.

Potential Side Effects of Accutane: Inflammatory Bowel Disease (IBD)
Inflammatory Bowel Disease (IBD) is defined as a group of inflammatory conditions of the colon and small intestine. The main forms of IBD are Crohn’s disease and ulcerative colitis. While the diseases have features in common, there are important differences.

Ulcerative colitis causes inflammation and sores (ulcers) in the lining of the rectum and colon. The sores form when inflammation has killed the cells that line the colon, which then bleed and produce pus. The main symptom of the disease is recurrent diarrhea mixed with blood. Mucus may also appear in the stool if the lining of the colon is damaged.

Crohn’s disease causes deeper inflammation than Ulcerative Colitis. It can potentially affect other parts of the digestive system, including the small intestine, anus, esophagus, mouth and stomach.

While Crohn’s disease has no known cure, ulcerative colitis can often be cured by surgery, but surgical removal of the large intestine and/or colon are as permanent and life-changing as the disease itself

About The Mulligan Law Firm
The Mulligan Law Firm is a national law firm located in Dallas, Texas, providing information and resources for injured individuals and their families in all 50 states. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995.

The Mulligan Law Firm is currently investigating injury claims involving Accutane’s possible role in inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis. Someone who has been seriously injured after taking Accutane should consult with a legal professional immediately, and the Mulligan Firm has experienced lawyers ready to help. Contact Eric Gruenwald, Lawyer/Attorney or Attorney/Lawyer at 866-529-0001, EXT 245.

All cases are taken on a contingency-fee basis, which means the prospective client does not pay for our services unless an award or compensation is received.

The Mulligan Law Firm is currently investigating injury claims involving Accutane’s possible role in inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis.

Someone who has been seriously injured after taking Accutane should consult with a legal professional immediately. The Mulligan Law Firm has experienced lawyers standing by to help them.

Dallas, TX September 30, 2009 — The Mulligan Law Firm is a national law firm located in Dallas, Texas, providing information and resources for injured individuals and their families in all 50 states. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995.

The Mulligan Law Firm is currently investigating injury claims involving Accutane’s possible role in inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis. Someone who has been seriously injured after taking Accutane should consult with a legal professional immediately. The Mulligan Firm has experienced lawyers standing by to help them. Contact Eric Gruenwald, Lawyer/Attorney or Attorney/Lawyer at 866-529-0001, EXT 245.

Along with other side-effects, Accutane® is suspected as a possible cause of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. Even after treatment with Accutane has been discontinued, these serious digestive disorders can persist. While Crohn’s disease has no known cure, ulcerative colitis can often be cured by surgery, but surgical removal of the large intestine and/or colon are as permanent and life-changing as the disease itself.

In the United States, several jury trials have awarded at least $33 million dollars to patients as compensation for injuries attributed to Accutane use. The total number of claims against Roche Holding Ltd., the maker of Accutane, is believed to exceed 5,000, with at least 425 injury cases pending.

After the outcome of these jury trials, Roche Pharmaceuticals notified the FDA that they were immediately discontinuing the distribution and manufacture of Accutane in the United States. One of the reasons given by Roche for the decision: the high cost of personal-injury lawsuits.

The Mulligan Law Firm takes all cases on a contingency-fee basis, which means the prospective client does not pay for our services unless an award or compensation is received.

About Accutane
Accutane (also known as Isotretinoin) has been used by about 13 million people since it first became available in 1982. Its primary use is for the treatment of severe nodular acne, in patients who fail to respond to other acne treatments such as antibiotics.

Accutane works by reducing the amount of oil released by oil-glands in the skin, and helps the skin to renew itself. Accutane was Roche’s second-biggest selling drug until the patent expired in 2003, at which time generic versions could be sold.

The names of these generic versions of Isotretinoin/Acutane are Amnesteem®, Claravis™, Clarus™, Decutan, Isotane, Izotek, Oratane®, Sotret®, Isotrex®, and Isotrexin®.

Avandia® or rosiglitazone maleate is a prescription drug for diabetics. Manufactured by GlaxoSmithKline, this is specifically used to treat Type II diabetes or non-insulin dependent diabetes. The drug works by helping to control blood sugar levels.

Side Effects of Avandia®
Some of the common side effects resulting from the use of Avandia® are headaches, weight gain, back pain, anemia, broken bones, and increased susceptibility to bruising. The more severe side effects are congestive heart failure and heart attacks. Congestive heart failure can be fatal as the heart will be unable to pump well enough to meet the body’s demand for oxygen. Heart failure symptoms include breathlessness, difficulty in breathing, chest pain, and swelling of the extremities. Heart attacks can also be caused by this drug.

Those who have increased vulnerability to side effects arising from Avandia® use are patients with cardiovascular disease, diabetes-related eye problems, liver disease, and stroke.

FDA & Avandia®
An FDA Alert on 19th November, 2007 called for Avandia®’s manufacturer to modify the prescribing information for rosiglitazone (Avandia®) including a new Boxed Warning. It also called for changes to the label stating the potential increased risk of myocardial ischemia. FDA also requested the manufacturer to create a Medication Guide for patient use that would contain guidelines on the use of rosiglitazone.

On 14th August,2007, FDA announced yet another alert. It called for a new Boxed Warning on Avandia®. It also asked them to update the content under Warnings, Precautions and Contraindications stressing that rosiglitazone could cause or exacerbate heart failure, especially in certain patients. Never stop any medication, including Avandia®, unless under the specific directions of your fully informed and licensed physician / medical doctor

The Law & Avandia®
If you or your loved ones have used Avandia and suffered from side effects like congestive heart failure or heart attacks, you could be entitled to compensation. Contact Eric W. Gruenwald, Attorney / Lawyer for more information at 866-529-0001 Extension 245.

The Zimmer Durom® Cup is an artificial hip component used in hip replacement surgeries. It has been used in Total Hip Arthroplasty (THA) surgeries in the USA and overseas for hip resurfacings. Manufactured by Zimmer Holdings Ltd, it is a solid metal cup made from cobalt chromium alloy and sprayed with a titanium plasma-sprayed coating. It was introduced in 2006 and has been implanted in an estimated 12,000 patients.

Side Effects of the Zimmer Durom® Cup
The side effects reported with the Zimmer Durom® Cup were blood clots, infections, changing of leg length, feeling of the leg giving away, difficulty in climbing, pain in the groin, joint stiffening, loosening of the cup causing pain or even breakage of the Durom® cup inside the body. Many have been forced to have revision or additional surgery done to correct the problem. Usually, symptoms appeared after 90 days of surgery or more.

FDA & the Zimmer Durom® Cup
The Zimmer Durom® Cup was approved by the FDA in 2006. Later, Zimmer found itself under mounting FDA pressure, and on July 22, 2008,  temporarily suspended marketing and distribution of the device.

It also sent a letter to U.S. orthopedic surgeons asking them to stop using this product. However, this seemed just a cosmetic initiative as it later resumed sales shifting the blame onto surgical error for the problems.

Who We Are
Have you or your loved ones faced hip complications as a result of using the Zimmer Durom® Cup? Don’t wait, you could be potentially entitled to compensation.
Contact Eric W. Gruenwald, Attorney / Lawyer for more information at 866-529-0001 Extension 245.